A Study of FT1 in Healthy Adult Volunteers

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 20, 2024

Primary Completion Date

March 6, 2025

Study Completion Date

May 6, 2025

Conditions

Diarrhea Caused by Drug (Disorder)

Interventions

DRUG

FT1

Six dose levels will be evaluated in single-dose part, and three dose levels in multiple-dose part.

DRUG

Placebo

Placebo will be administered.

Trial Locations (1)

RECRUITING

Bishan Hospital of Chongqing, Chongqing

All Listed Sponsors

lead

Chongqing Peg-Bio Biopharm Co., Ltd.

INDUSTRY